Proxy Votes Now

Home › Funds › T. Rowe Price › T. Rowe Price Small-Cap Stock Fund, Inc.

T. Rowe Price Small-Cap Stock Fund, Inc. (OTCFX) proxy voting record 2025-2026

Fund family: T. Rowe Price · Filed by T. Rowe Price Small-Cap Stock Fund, Inc. (CIK 75170) · SEC series S000002120

Share classes and tickers: OTCFX (C000005508), OTIIX (C000159682), PASSX (C000005509), TRZZX (C000219319)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,187 with, 20 against, 0 abstentions (not counted as with management); 1 items carried no recommendation; 6 split votes are in neither count. Shareholder proposals: 2 FOR, 7 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with T. Rowe Price as a whole

The same two figures as T. Rowe Price’s manager page (244,024 ballot items across 112 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsT. Rowe PriceItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)92.5%2,10693.7%208,710
Backed environmental and social shareholder proposals at US companiesn/a22.6%3,333

Where this fund voted differently from most T. Rowe Price funds

Each ballot item this fund voted is set against the votes of the other T. Rowe Price funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most T. Rowe Price funds on 42 items (1.9% of the 2,160 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost T. Rowe Price fundsMgmtResult
Guardant Health, Inc.2026-06-17Election of Class II Directors: Ian ClarkWithholdFOR — 16 of 21 T. Rowe Price fundsAgainstElected, 65.0% support
Guardant Health, Inc.2026-06-17Election of Class II Directors: Manuel Hidalgo MedinaWithholdFOR — 16 of 21 T. Rowe Price fundsAgainstElected, 75.5% support
Rambus Inc.2026-04-23Election of Directors: Meera RaoForAGAINST — 14 of 18 T. Rowe Price fundsForPassed (calculated), 93.9% support
Rambus Inc.2026-04-23Election of Directors: Necip SayinerForAGAINST — 14 of 18 T. Rowe Price fundsForPassed (calculated), 93.5% support
Viper Energy, Inc.2026-05-19The approval, on an advisory basis, of the compensation of the Company's named executive officers.ForAGAINST — 15 of 20 T. Rowe Price fundsForApproved, 86.8% support
Viper Energy, Inc.2026-05-19The approval of an amendment to the Company's certificate of incorporation to provide that stockholders holding at least 20% of the voting power, determined on a net long basis, continuously for at least one year, may call special meetings of stockholders, and other immaterial changesAgainstFOR — 12 of 16 T. Rowe Price fundsAgainst—
WaterBridge Infrastructure LLC2026-06-18To elect the 13 directors identified in the Proxy Statement to serve for a one-year term or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal (Proposal No. 1): Ben MooreForWITHHOLD — 4 of 4 T. Rowe Price fundsForElected, 83.8% support
WaterBridge Infrastructure LLC2026-06-18To elect the 13 directors identified in the Proxy Statement to serve for a one-year term or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal (Proposal No. 1): David N. CapobiancoForWITHHOLD — 4 of 4 T. Rowe Price fundsForElected, 83.8% support
WaterBridge Infrastructure LLC2026-06-18To elect the 13 directors identified in the Proxy Statement to serve for a one-year term or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal (Proposal No. 1): Frank BayouthForWITHHOLD — 4 of 4 T. Rowe Price fundsForElected, 83.8% support
WaterBridge Infrastructure LLC2026-06-18To elect the 13 directors identified in the Proxy Statement to serve for a one-year term or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal (Proposal No. 1): Jeffrey EatonForWITHHOLD — 4 of 4 T. Rowe Price fundsForElected, 83.8% support
WaterBridge Infrastructure LLC2026-06-18To elect the 13 directors identified in the Proxy Statement to serve for a one-year term or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal (Proposal No. 1): Jeffrey RitenourForWITHHOLD — 4 of 4 T. Rowe Price fundsForElected, 83.8% support
WaterBridge Infrastructure LLC2026-06-18To elect the 13 directors identified in the Proxy Statement to serve for a one-year term or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal (Proposal No. 1): Kara Goodloe HarlingForWITHHOLD — 4 of 4 T. Rowe Price fundsForElected, 83.8% support
WaterBridge Infrastructure LLC2026-06-18To elect the 13 directors identified in the Proxy Statement to serve for a one-year term or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal (Proposal No. 1): Matthew K. MorrowForWITHHOLD — 4 of 4 T. Rowe Price fundsForElected, 83.8% support
WaterBridge Infrastructure LLC2026-06-18To elect the 13 directors identified in the Proxy Statement to serve for a one-year term or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal (Proposal No. 1): Michael S. SultonForWITHHOLD — 4 of 4 T. Rowe Price fundsForElected, 83.8% support
Secure Waste Infrastructure Corp.2026-05-27Approve Acquisition by GFL Environmental Inc.AgainstFOR — 4 of 4 T. Rowe Price fundsAgainst—
Topaz Energy Corp.2026-05-08Elect Director Darlene HarrisForWITHHOLD — 4 of 4 T. Rowe Price fundsFor—
Weatherford International plc2026-06-11Scheme Related Business If the Scheme of Arrangement proposal is approved at the Court Meeting: To approve the Scheme of Arrangement by, and on behalf of, Weatherford International plc ("Weatherford-Ireland') and to authorize the directors of Weatherford-Ireland to take all such actions as they consAgainstFOR — 10 of 14 T. Rowe Price fundsAgainstPassed (calculated), 61.0% support
Weatherford International plc2026-06-11To agree to a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014, as amended, substantially in the form attached as Annex C to the Proxy Statement, that, once it becomes effective, will result in you owning common stock of Weatherford International Corp Instead of ordinary shaAgainstFOR — 10 of 14 T. Rowe Price fundsAgainst—
Weatherford International plc2026-06-11To approve a capital reduction under sections 84 to 86 of the Companies Act to effect the cancellation of Weatherford-Ireland ordinary shares contemplated by the Scheme of Arrangement.AgainstFOR — 10 of 14 T. Rowe Price fundsAgainstPassed (calculated), 63.9% support
Weatherford International plc2026-06-11To approve an amendment to the Weatherford-Ireland Articles so that any Weatherford-Ireland ordinary shares that are issued on or after the Voting Record Time to persons other than Weatherford-US or its nominee(s) will either be subject to the terms of the Scheme of Arrangement or will be immediatelAgainstFOR — 10 of 14 T. Rowe Price fundsAgainstPassed (calculated), 61.0% support
Weatherford International plc2026-06-11To approve the terms of an initial subscription, allotment and issue of one, or more, Weatherford-Ireland ordinary shares to Weatherford International Corp ("Weatherford-US") in connection with the Scheme of Arrangement.AgainstFOR — 10 of 14 T. Rowe Price fundsAgainstPassed (calculated), 64.7% support
Weatherford International plc2026-06-11To authorize the directors of Weatherford-Ireland to allot and issue further new Weatherford-Ireland ordinary shares to Weatherford-US in connection with the Scheme of Arrangement to be paid up by the application of certain reserves as described in the Scheme of Arrangement.AgainstFOR — 10 of 14 T. Rowe Price fundsAgainstPassed (calculated), 66.3% support
Marex Group plc2026-05-21Amend Articles of AssociationAgainstFOR — 9 of 13 T. Rowe Price fundsAgainst—
Marex Group plc2026-05-21Approve Capital Reduction by Cancellation and Extinguishment of the Deferred SharesAgainstFOR — 9 of 13 T. Rowe Price fundsAgainst—
Marex Group plc2026-05-21Approve Capital Reduction by Cancellation and Extinguishment of the Scheme SharesAgainstFOR — 9 of 13 T. Rowe Price fundsAgainst—
Show all 42
Items 26 to 42.
CompanyMeetingItemThis fundMost T. Rowe Price fundsMgmtResult
Marex Group plc2026-05-21Approve Scheme of ArrangementAgainstFOR — 9 of 13 T. Rowe Price fundsAgainst—
Crinetics Pharmaceuticals, Inc.2026-06-18To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Caren DeardorfWithholdFOR — 10 of 15 T. Rowe Price fundsAgainstPassed (calculated), 75.7% support
Crinetics Pharmaceuticals, Inc.2026-06-18To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Stephanie S. Okey, M.S.WithholdFOR — 10 of 15 T. Rowe Price fundsAgainstPassed (calculated), 74.5% support
Marex Group Plc2026-05-21Approve Scheme of ArrangementAgainstFOR — 9 of 13 T. Rowe Price fundsAgainst—
Rocket Companies, Inc.2026-06-10Election of Class III Directors: Varun KrishnaWithholdFOR — 11 of 17 T. Rowe Price fundsAgainstPassed (calculated), 87.9% support
Ionis Pharmaceuticals, Inc.2026-06-04Election of Directors: Joan E. HermanForAGAINST — 13 of 21 T. Rowe Price fundsForPassed (calculated), 96.4% support
Planet Fitness, Inc.2026-05-05Election of the four director nominees named in the proxy statement as set forth below: Enshalla AndersonForWITHHOLD — 12 of 19 T. Rowe Price fundsForElected, 92.2% support
Planet Fitness, Inc.2026-05-05Election of the four director nominees named in the proxy statement as set forth below: Stephen Spinelli, Jr.ForWITHHOLD — 12 of 19 T. Rowe Price fundsForElected, 73.5% support
Dianthus Therapeutics, Inc.2026-05-21To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Anne McGeorgeWithholdFOR — 9 of 15 T. Rowe Price fundsAgainstPassed (calculated), 80.6% support
Kodiak Sciences Inc.2026-06-02Elect three Class II directors nominated by our board and named in this proxy statement: Charles A. BancroftWithholdFOR — 8 of 14 T. Rowe Price fundsAgainstElected, 78.7% support
Denali Therapeutics Inc.2026-06-03ELECTION OF DIRECTORS: David Schenkein, M.D.WithholdFOR — 8 of 14 T. Rowe Price fundsAgainstElected, 73.5% support
Denali Therapeutics Inc.2026-06-03ELECTION OF DIRECTORS: Jennifer CookWithholdFOR — 8 of 14 T. Rowe Price fundsAgainstElected, 60.9% support
Impinj, Inc.2026-05-28Election of Directors: Steve SanghiAgainstFOR — 7 of 12 T. Rowe Price fundsAgainstElected, 68.1% support
Marqeta, Inc.2026-06-10To approve, on a non-binding advisory basis, the compensation of our named executive officers.AgainstFOR — 7 of 13 T. Rowe Price fundsAgainstPassed (calculated), 78.5% support
MapLight Therapeutics, Inc.2026-06-23To elect the three Class I Director nominees named in the Proxy Statement to serve until the 2029 annual meeting of our stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Martin BablerWithholdFOR — 7 of 13 T. Rowe Price fundsAgainst—
Installed Building Products, Inc.2026-05-19Election of Directors to serve for three-year terms: Robert H. SchottensteinForAGAINST — 6 of 11 T. Rowe Price fundsForElected, 93.9% support
Xenon Pharmaceuticals Inc.2026-06-02To approve the Corporation's 2026 Equity Incentive Plan;ForAGAINST — 6 of 11 T. Rowe Price fundsForApproved, 68.0% support

Download all 42 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 83.6% of this fund’s 2,207 such votes could be given a sector; the other 361 (16.4%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Finance427112.6%
Consumer Discretionary31531.0%
Industrials31320.6%
Health Care27800.0%
Technology18110.6%
Energy12500.0%
Real Estate6100.0%
Utilities5711.8%
Consumer Staples3700.0%
Basic Materials2500.0%
Miscellaneous2100.0%
Telecommunications600.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections1,5317
Audit-related2431
Say-on-Pay2231
Corporate Governance777
Compensation741
Capital Structure380
Extraordinary Transactions281
Other150
Shareholder Rights and Defenses60
Other Social Issues30

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Lattice Semiconductor CorporationMay 1, 2026$198M100
BrightSpring Health Services, Inc.May 21, 2026$173M50
VSE CorporationMay 7, 2026$156M110
Marqeta, Inc.June 10, 2026$150M80
RBC Bearings IncorporatedSeptember 4, 2025$127M60
Dyne Therapeutics, Inc.June 5, 2026$117M70
Loar Holdings Inc.June 2, 2026$113M60
Elanco Animal Health IncorporatedMay 21, 2026$110M70

Notable votes against management

MeetingCompanyProposalFundMgmt
May 6, 2026Entegris, Inc.Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders. Shareholder proposalAgainstFor
May 14, 2026Cboe Global Markets, Inc.Stockholder proposal regarding shareholder right to act by written consent. Shareholder proposalAgainstFor
May 14, 2026OGE Energy Corp.Shareholder Proposal Regarding Simple Majority Vote. Shareholder proposalForAgainst
May 19, 2026Live Oak Bancshares, Inc.Election of Directors: Tonya W. BradfordForAgainst
May 19, 2026Live Oak Bancshares, Inc.Election of Directors: David G. LuchtForAgainst
June 18, 2026BJ's Wholesale Club Holdings, Inc.Vote on a shareholder proposal regarding adopting a majority voting standard, if properly presented at the meeting. Shareholder proposalAgainstFor
June 18, 2026BJ's Wholesale Club Holdings, Inc.Vote on a shareholder proposal regarding a report on greenhouse gas emissions reduction efforts, if properly presented at the meeting. Shareholder proposalAgainstFor
May 14, 2026Flowserve CorporationShareholder Proposal requesting an annual advisory shareholder vote regarding Flowserve stock repurchases. Shareholder proposalAgainstFor
June 25, 2026BlackBerry LimitedShareholder Proposal - shareholder proposal as disclosed in the Management Proxy Circular for the Meeting. Shareholder proposalAgainstFor
December 11, 2025Sportradar Group AGAdditional Voting Instructions - Shareholder Proposals (Voting)AgainstFor
January 29, 2026Blue Foundry BancorpA proposal to approve and adopt the Agreement and Plan of Merger, dated as of November 24, 2025, by and between Fulton Financial Corporation and Blue Foundry Bancorp (the "Blue Foundry merger proposal");ForAgainst

Funds that vote the same way

These funds reported the same votes as T. Rowe Price Small-Cap Stock Fund, Inc. in the latest season (or all but a few items), so they share this page:

Search this fund’s votes by company

2,240 ballot items at 255 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, T. Rowe Price Small-Cap Stock Fund, Inc. (OTCFX) voted at 255 shareholder meetings of 246 companies, on 2,240 ballot items in all. Where management made a recommendation, the fund followed it on 99.1% of the items and voted against it 20 times. Its most frequent area of disagreement was director elections (7 of its votes against management). It voted on 9 shareholder proposals. It voted FOR the board's own proposals less often than T. Rowe Price's funds as a whole (92.5% against 93.7%). It voted differently from most T. Rowe Price funds on 42 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of T. Rowe Price’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.